Cite this abstract
http://echo.ismrm.org/p/ISMRM2026/363-03-002
363-03-002
MRI in Clinical Practice Abstract
MRI in Clinical Practice: Differentiating IgG4-related sclerosing cholangitis from cholangiocarcinoma
Accepted
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
Log inReferences
1. Swensson J, Tirkes T, Tann M, Cui E, Sandrasegaran K. Differentiating IgG4-related sclerosing cholangiopathy from cholangiocarcinoma using CT and MRI: experience from a tertiary referring center. Abdom Radiol (NY). 2019 Jun;44(6):2111-2115. DOI: 10.1007/s00261-019-01944-1. [doi]
2. Naitoh I, Kamisawa T, Tanaka A, Nakazawa T, Kubota K, Takikawa H, Unno M, Masamune A, Kawa S, Nakamura S et al.Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: Comparison of cases with and without autoimmune pancreatitis in a large cohort. Dig Liver Dis 2021, 53(10):1308-1314. DOI: 10.1016/j.dld.2021.02.009 [doi]
3. Naitoh I, Nakazawa T. Classification and Diagnostic Criteria for IgG4-Related Sclerosing Cholangitis. Gut Liver. 2022 Jan 15;16(1):28-36. DOI: 10.5009/gnl210116 [doi]
4. Kamisawa T, Nakazawa T, Tazuma S, Zen Y, Tanaka A, Ohara H, Muraki T, Inui K, Inoue D, Nishino T et al: Clinical practice guidelines for IgG4-related sclerosing cholangitis. J Hepatobiliary Pancreat Sci 2019, 26(1):9-42.DOI: 10.1002/jhbp.596 [doi]